Regulatory Data Excellence Pinnacle 21 by Certara specializes in validating data quality and CDISC standard compliance for regulatory submissions, presenting a sales opportunity to life sciences companies seeking streamlined health authority filings and faster approvals.

Data Pipelines With a focus on creating smooth data pipelines from Data Management and Biostatistics to regulatory bodies like FDA, PMDA, and NMPA, there is potential to upsell end-to-end data management, validation automation, and integration services within Certara's data sciences platform.

AI & Automation Certara’s recent push into agentic AI workflows and Python API integration signals a traction point for selling advanced analytics, automation tooling, and AI-driven data quality checks to accelerate submissions and reduce manual effort.

Cost & Efficiency Public signals of rising costs and quarterly profitability challenges at Certara suggest opportunities to offer cost-optimization software, cloud optimization, or managed services that improve margins for clients navigating regulatory data workflows.

Strategic Partnerships Certara’s ecosystem, including NVIDIA collaboration and acquisitions/divestitures around regulatory and medical writing assets, indicates openings for co-sell with complementary vendors, expansion into pharmacovigilance data services, or cross-sell of platform modules to existing customers.